SLC5A2 and type 2 diabetes mellitus: These medications have revolutionized diabetic treatment protocols by lowering patients’ blood glucose, blood pressure, and uric acid, while also promoting weight loss, and improving patients’ cardio-renal outcomes in patients with type 2 diabetes.1,2 The most dangerous complication of SGLT-2 inhibitors is possible precipitation of euglycemic DKA (eDKA), a state of DKA in which the serum glucose level is grossly normal (less than 200 mg/dL).